168 related articles for article (PubMed ID: 26319638)
1. Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product.
Rahman Z; Korang-Yeboah M; Siddiqui A; Mohammad A; Khan MA
Int J Pharm; 2015 Nov; 495(1):19-30. PubMed ID: 26319638
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin Sodium.
Nguyenpho A; Ciavarella AB; Siddiqui A; Rahman Z; Akhtar S; Hunt R; Korang-Yeboah M; Khan MA
J Pharm Sci; 2015 Dec; 104(12):4232-4240. PubMed ID: 26501849
[TBL] [Abstract][Full Text] [Related]
3. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
[TBL] [Abstract][Full Text] [Related]
4. Studying effect of glyceryl palmitostearate amount, manufacturing method and stability on polymorphic transformation and dissolution of rifaximin tablets.
Dharani S; Barakh Ali SF; Afrooz H; Khan MA; Rahman Z
Int J Pharm; 2020 Nov; 589():119785. PubMed ID: 32822778
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of X-ray diffraction method for quantitative determination of crystallinity in warfarin sodium products.
Siddiqui A; Rahman Z; Korang-Yeboah M; Khan MA
Int J Pharm; 2015 Sep; 493(1-2):1-6. PubMed ID: 26209072
[TBL] [Abstract][Full Text] [Related]
6. Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product.
Korang-Yeboah M; Akhtar S; Siddiqui A; Rahman Z; Khan MA
Drug Dev Ind Pharm; 2016; 42(4):584-94. PubMed ID: 26161939
[TBL] [Abstract][Full Text] [Related]
7. Physical chemical stability of warfarin sodium.
Gao D; Maurin MB
AAPS PharmSci; 2001; 3(1):E3. PubMed ID: 11741254
[TBL] [Abstract][Full Text] [Related]
8. Chemometric Model Development and Comparison of Raman and (13)C Solid-State Nuclear Magnetic Resonance-Chemometric Methods for Quantification of Crystalline/Amorphous Warfarin Sodium Fraction in the Formulations.
Rahman Z; Mohammad A; Akhtar S; Siddiqui A; Korang-Yeboah M; Khan MA
J Pharm Sci; 2015 Aug; 104(8):2550-8. PubMed ID: 26096869
[TBL] [Abstract][Full Text] [Related]
9. Effect of processing parameters and controlled environment storage on the disproportionation and dissolution of extended-release capsule of phenytoin sodium.
Rahman Z; Dharani S; Barakh Ali SF; Afrooz H; Reddy IK; Khan MA
Int J Pharm; 2018 Oct; 550(1-2):290-299. PubMed ID: 30031866
[TBL] [Abstract][Full Text] [Related]
10. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
11. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
12. Nanoamorphous drug products - Design and development.
Jog R; Burgess DJ
Int J Pharm; 2018 Dec; 553(1-2):238-260. PubMed ID: 30359685
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
14. A headspace-gas chromatography method for isopropanol determination in warfarin sodium products as a measure of drug crystallinity.
Rahman Z; Akhtar S; Siddiqui A; Ciavarella AB; Nguyenpho A; Faustino PJ; Khan MA
Acta Pharm; 2018 Mar; 68(1):31-46. PubMed ID: 29453909
[TBL] [Abstract][Full Text] [Related]
15. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
16. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
17. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
Otsuka M; Kanai Y; Hattori Y
J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
[TBL] [Abstract][Full Text] [Related]
18. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
Patterson J; Bary A; Rades T
Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights into Warfarin Sodium 2-Propanol Solvate Solid Form Changes and Disproportionation Using a Low Volume Two-Stage Dissolution Approach.
Shah HS; Chaturvedi K; Dave RH; Morris KR
Mol Pharm; 2021 Apr; 18(4):1779-1791. PubMed ID: 33689375
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
Sawicki E; Schellens JH; Beijnen JH; Nuijen B
Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
